Vetoquinol SA (0O1O.L)

EUR 76.5

(0.0%)

Operating Income Summary of Vetoquinol SA

  • Vetoquinol SA's latest annual operating income in 2023 was 74.26 Million EUR , down -43.39% from previous year.
  • Vetoquinol SA's latest quarterly operating income in 2024 Q2 was 33.03 Million EUR , down 0.0% from previous quarter.
  • Vetoquinol SA reported an annual operating income of 79.31 Million EUR in 2022, up 2.64% from previous year.
  • Vetoquinol SA reported an annual operating income of 77.27 Million EUR in 2021, up 47.21% from previous year.
  • Vetoquinol SA reported a quarterly operating income of 35.91 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Vetoquinol SA reported a quarterly operating income of 20.1 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Operating Income of Vetoquinol SA (2023 - 2005)

Year Operating Income Operating Income Growth
2023 74.26 Million EUR -43.39%
2022 79.31 Million EUR 2.64%
2021 77.27 Million EUR 47.21%
2020 52.49 Million EUR 14.16%
2019 45.98 Million EUR -4.75%
2018 48.27 Million EUR 5.76%
2017 45.64 Million EUR 8.49%
2016 42.07 Million EUR 8.58%
2015 38.74 Million EUR 10.22%
2014 35.15 Million EUR 4.82%
2013 33.53 Million EUR 6.66%
2012 31.44 Million EUR -1.18%
2011 31.82 Million EUR -1.03%
2010 32.15 Million EUR 11.15%
2009 28.92 Million EUR 4.85%
2008 27.58 Million EUR -1.75%
2007 28.07 Million EUR 12.98%
2006 24.85 Million EUR 31.94%
2005 18.83 Million EUR 0.0%

Peer Operating Income Comparison of Vetoquinol SA

Name Operating Income Operating Income Difference
Boiron SA 42.29 Million EUR -75.607%
Laboratorios Farmaceuticos Rovi, S.A. 220.25 Million EUR 66.283%
Valneva SE -82.08 Million EUR 190.47%
AB Science S.A. -13.42 Million EUR 653.012%
Nanobiotix S.A. -26.77 Million EUR 377.322%
PHAXIAM Therapeutics S.A. -23.66 Million EUR 413.88%
Vivoryon Therapeutics N.V. -28.83 Million EUR 357.53%
BioSenic S.A. -7.04 Million EUR 1154.886%
ABIVAX Société Anonyme -127.37 Million EUR 158.303%
Formycon AG -369 Thousand EUR 20225.745%